Article

An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling

The Skaggs Institute for Chemical Biology and Departments of Cell Biology and Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Chemistry & Biology (Impact Factor: 6.59). 11/2006; 13(10):1041-50. DOI: 10.1016/j.chembiol.2006.08.008
Source: PubMed

ABSTRACT Hundreds, if not thousands, of uncharacterized enzymes currently populate the human proteome. Assembly of these proteins into the metabolic and signaling pathways that govern cell physiology and pathology constitutes a grand experimental challenge. Here, we address this problem by using a multidimensional profiling strategy that combines activity-based proteomics and metabolomics. This approach determined that KIAA1363, an uncharacterized enzyme highly elevated in aggressive cancer cells, serves as a central node in an ether lipid signaling network that bridges platelet-activating factor and lysophosphatidic acid. Biochemical studies confirmed that KIAA1363 regulates this pathway by hydrolyzing the metabolic intermediate 2-acetyl monoalkylglycerol. Inactivation of KIAA1363 disrupted ether lipid metabolism in cancer cells and impaired cell migration and tumor growth in vivo. The integrated molecular profiling method described herein should facilitate the functional annotation of metabolic enzymes in any living system.

0 Followers
 · 
108 Views
  • Source
    • "In addition to HAG, cholesterol esters (CE) have been reported to be AADACL1 substrates in mouse macrophages, but this substrate assignment is controversial and complicated by the expression of several potentially redundant CE hydrolases in macrophages (Buchebner et al., 2010; Sekiya et al., 2009). AADACL1 does not hydrolyze abundant phospholipids such as phosphatidylcholine or the bioactive ether lipid plateletactivating factor (Chiang et al., 2006). Therefore, 2-acetyl MAGE is the only undisputed physiologic substrate for AADACL1, but even so, it may not totally account for the inhibitory effects of WWL91 or JW480 in platelets. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A comprehensive knowledge of the platelet proteome is necessary for understanding thrombosis and for envisioning antiplatelet therapies. To discover other biochemical pathways in human platelets, we screened platelets with a carbamate library designed to interrogate the serine hydrolase subproteome and used competitive activity-based protein profiling to map the targets of active carbamates. We identified an inhibitor that targets arylacetamide deacetylase-like 1 (AADACL1), a lipid deacetylase originally identified in invasive cancers. Using this compound, along with highly selective second-generation inhibitors of AADACL1, metabolomics, and RNA interference, we show that AADACL1 regulates platelet aggregation, thrombus growth, RAP1 and PKC activation, lipid metabolism, and fibrinogen binding to platelets and megakaryocytes. These data provide evidence that AADACL1 regulates platelet and megakaryocyte activation and highlight the value of this chemoproteomic strategy for target discovery in platelets.
    Chemistry & biology 08/2013; DOI:10.1016/j.chembiol.2013.07.011 · 6.59 Impact Factor
  • Source
    • "In particular, because of the modern multidisciplinary approaches , in recent years we have assisted to an improved peptidome and lipidome coverage [6] [7] [8]. Endogenous peptides (PT)/proteins and lipids (LP) represent two important classes of biomolecules owing to their multiple biological roles in physiological and in pathological conditions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Herein we report the use of mesoporous aluminosilicate (MPAS) for the simultaneous extraction of peptides and lipids from complex body fluids such as human plasma and synovial fluid. We show that MPAS particles, given their mesostructural features with nanometric pore size and high surface area, are an efficient device for simultaneous extraction of peptidome and lipidome from as little as a few microliters of body fluids. The peptides and the lipids, selected and enriched by MPAS particles and rapidly visualized by MALDI-TOF MS, could form part of a diagnostic profile of the "peptidome" and the "lipidome" of healthy versus diseased subjects in comparative studies. The ability of this approach to rapidly reveal the overall pattern of changes in both lipidome and peptidome signatures of complex biofluids could be of valuable interest for handling large numbers of samples required in -omics studies for the purpose of finding novel biomarkers.
    Proteomics 11/2012; 12(22). DOI:10.1002/pmic.201200204 · 3.97 Impact Factor
  • Source
    • "Diacylglycerol cholinephosphotransferase 2.7.8.2 (X) Acetylalkylglycerol acetylhydrolase 3.1.1.71 [48] (Y) 1-Alkyl-2-acetylglycerol O-acyltransferase 2.3.1.125 [60] (Z) Alkylglycerophosphocholine O-acetyltransferase 2.3.1.67 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ether lipids are an emerging class of lipids which have so far not been investigated and understood in every detail. They have important roles as membrane components of e.g. lens, brain and testis, and as mediators such as platelet-activating factor. The metabolic enzymes for biosynthesis and degradation have been investigated to some extent. As most involved enzymes are integral membrane proteins they are tricky to handle in biochemical protocols. The sequence of some ether lipid metabolising enzymes has only recently been reported and other sequences still remain obscure. Defined enzymes without assigned sequence are known as orphan enzymes. One of these enzymes with uncharacterised sequence is plasmanylethanolamine desaturase, a key enzyme for the biosynthesis of one of the most abundant phospholipids in our body, the plasmalogens. This review aims to briefly summarise known functions of ether lipids, give an overview on their metabolism including the most prominent members, platelet-activating factor and the plasmalogens. A special focus is set on the description of orphan enzymes in ether lipid metabolism and on the successful strategies how four previous orphans have recently been assigned a sequence. Only one of these four was characterised by classical protein purification and sequencing, whereas the other three required alternative strategies such as bioinformatic candidate gene selection and recombinant expression or development of an inhibitor and multidimensional metabolic profiling.
    Biochimie 07/2012; 95(1). DOI:10.1016/j.biochi.2012.06.027 · 3.12 Impact Factor

Preview

Download
1 Download
Available from